CME Group Inc (CME) Position Reduced by Los Angeles Capital Management & Equity Research Inc.

Los Angeles Capital Management & Equity Research Inc. lessened its position in CME Group Inc (NASDAQ:CME) by 3.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 214,994 shares of the financial services provider’s stock after selling 6,880 shares during the quarter. Los Angeles Capital Management & Equity Research Inc. owned about 0.06% of CME Group worth $36,594,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Edgewood Management LLC grew its position in CME Group by 2.8% in the 2nd quarter. Edgewood Management LLC now owns 7,840,451 shares of the financial services provider’s stock worth $1,285,207,000 after purchasing an additional 215,439 shares during the last quarter. Janus Henderson Group PLC grew its position in CME Group by 13.2% in the 2nd quarter. Janus Henderson Group PLC now owns 6,129,157 shares of the financial services provider’s stock worth $1,004,691,000 after purchasing an additional 716,655 shares during the last quarter. Thornburg Investment Management Inc. grew its position in CME Group by 3.8% in the 3rd quarter. Thornburg Investment Management Inc. now owns 3,614,874 shares of the financial services provider’s stock worth $615,288,000 after purchasing an additional 132,991 shares during the last quarter. Fiera Capital Corp grew its position in CME Group by 2.8% in the 2nd quarter. Fiera Capital Corp now owns 2,225,333 shares of the financial services provider’s stock worth $364,777,000 after purchasing an additional 60,825 shares during the last quarter. Finally, Standard Life Aberdeen plc grew its position in CME Group by 38.1% in the 2nd quarter. Standard Life Aberdeen plc now owns 1,765,929 shares of the financial services provider’s stock worth $289,472,000 after purchasing an additional 487,442 shares during the last quarter. Hedge funds and other institutional investors own 84.28% of the company’s stock.

Several analysts have issued reports on CME shares. BidaskClub lowered shares of CME Group from a “buy” rating to a “hold” rating in a research report on Tuesday, July 10th. Zacks Investment Research lowered shares of CME Group from a “hold” rating to a “sell” rating in a research report on Wednesday, August 22nd. Jefferies Financial Group restated a “buy” rating and issued a $190.00 price target on shares of CME Group in a research report on Wednesday, September 5th. Rosenblatt Securities started coverage on shares of CME Group in a research report on Wednesday, September 5th. They issued a “neutral” rating and a $177.00 price target on the stock. Finally, Berenberg Bank set a $184.00 price target on shares of CME Group and gave the stock a “hold” rating in a research report on Thursday, September 20th. Five investment analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $182.69.

In other CME Group news, Director Ronald A. Pankau sold 260 shares of the business’s stock in a transaction dated Thursday, August 9th. The shares were sold at an average price of $163.17, for a total value of $42,424.20. Following the transaction, the director now directly owns 3,900 shares in the company, valued at $636,363. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Martin J. Gepsman sold 300 shares of the business’s stock in a transaction dated Thursday, September 13th. The shares were sold at an average price of $172.30, for a total transaction of $51,690.00. Following the completion of the transaction, the director now owns 42,912 shares in the company, valued at $7,393,737.60. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 20,479 shares of company stock worth $3,622,694. 0.43% of the stock is owned by company insiders.

Shares of CME Group stock opened at $186.40 on Wednesday. The company has a current ratio of 1.09, a quick ratio of 1.08 and a debt-to-equity ratio of 0.15. CME Group Inc has a twelve month low of $136.35 and a twelve month high of $188.49. The stock has a market cap of $62.42 billion, a PE ratio of 39.08, a price-to-earnings-growth ratio of 3.47 and a beta of 0.49.

CME Group (NASDAQ:CME) last issued its earnings results on Thursday, October 25th. The financial services provider reported $1.45 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.03. CME Group had a net margin of 113.67% and a return on equity of 9.18%. The business had revenue of $904.20 million for the quarter, compared to analyst estimates of $910.50 million. Research analysts forecast that CME Group Inc will post 6.63 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: “CME Group Inc (CME) Position Reduced by Los Angeles Capital Management & Equity Research Inc.” was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this news story on another domain, it was copied illegally and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this news story can be accessed at https://www.dispatchtribunal.com/2018/11/07/cme-group-inc-cme-position-reduced-by-los-angeles-capital-management-equity-research-inc.html.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

See Also: Does the discount rate affect the economy?

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply